BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Arbor Pharmaceuticals Announces Acquisition by Investment Group


4/13/2010 8:49:20 AM

RALEIGH, N.C., April 13 /PRNewswire/ -- Arbor Pharmaceuticals, a specialty pharmaceutical company focused on pediatric medicine, announced today that an investment group led by Jason Wild of JW Asset Management, LLC and Edward Schutter has acquired the company. Jason Wild has been named Chairman of the Board at Arbor Pharmaceuticals, and Edward Schutter was named Chief Executive Officer and has also been elected to serve on the board of directors. Joining Mr. Wild and Mr. Schutter as a director and a member of the investment group is Dr. Allen Chao, founder and former CEO of Watson Pharmaceuticals. Jarrett Disbrow, founder and CEO of Arbor prior to the acquisition will remain with the company as Vice President of Commercial Development.

Arbor Pharmaceuticals currently offers products to treat symptoms of otitis media, otitis externa and atopic dermatitis, all common conditions in the pediatric population. Jarrett Disbrow, founder and former CEO of Arbor, said, "We have been very pleased with our progress at Arbor and I want to thank all of our team members and investors for their help in growing the company to this point. We have built an outstanding pediatric franchise and believe that the new investors have the resources necessary to maximize the potential of Arbor's marketed and pipeline products."

About Arbor Pharmaceuticals, Inc.

Arbor Pharmaceuticals, headquartered in Raleigh, North Carolina, is a specialty pharmaceutical company focused exclusively on the growing pediatric market. The company intends to become the leading pediatrics-focused pharmaceutical company by actively licensing, developing and commercializing late-stage products for significant pediatric conditions. Arbor currently markets three nonantibiotic products for varying otic conditions including XYLAREX(R), ZINOTIC(R) and NEOTIC(R) as well as PEDIADERM(TM) HC COMPLETE KIT for atopic dermatitis.

About JW Asset Management, LLC

JW Asset Management is a New York based fund manager for three investment partnerships. Jason Wild, a registered pharmacist, is the firm's founder and chief investment officer. JW Asset Management was founded in 1997 and has a strong history of finding opportunities within the specialty pharmaceutical sector. The firm is active in both the public and private equity markets.

CONTACT: Jarrett Disbrow, +1-919-792-1701

Web site: http://www.arborpharma.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES